Get Cash Back and $0 Commissions + The Power of TradeStation
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of APOG, IGCC, NKTR, TSRO and APHA
Globe Newswire 12-Dec-2018 2:07 PM
NEW YORK, Dec. 12, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Apogee Enterprises, Inc. (NASDAQ:APOG) Class Period: June 28, 2018 to September 17, 2018 Lead Plaintiff Deadline: January 4, 2019
The lawsuit alleges Apogee Enterprises, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Apogee lacked the required labor force in place to ramp-up its production; (ii) Apogee was unable to hire, train and retain new employees; (iii) Apogee's productivity and margins would be negatively impacted; and (iv) as a result of the foregoing, Defendants' statements about the Company's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
India Globalization Capital Inc. (OCTMKTS: IGCC) Class Period: October 25, 2017 to October 29, 2018 Lead Plaintiff Deadline: January 2, 2019
Throughout the class period, India Globalization Capital Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) India Globalization's business model was in a state of change in order to lure potential blockchain and cannabis investors; (2) India Globalization had overstated the benefits of its relationships with manufacturers, partners, and distributors in order to inflate the Company's potential commercial success in the blockchain and cannabis markets; (3) as a result, the NYSE delisted India Globalization's shares from their exchange; and (4) consequently, Defendants' statements about India Globalization's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. On October 29, 2018 India Globalization announced that NYSE Regulation would begin the process of delisting the Company and trading would halt immediately.
Nektar Therapeutics (NASDAQ:NKTR) Class Period: November 11, 2017 to October 2, 2018 Lead Plaintiff Deadline: December 31, 2018
The lawsuit alleges that Nektar Therapeutics made materially false and/or misleading statements and/or failed to disclose that: (1) prior studies which attempted to pegylate IL-2 failed; (2) the extended half-life of the Company's lead I-O candidate, NKTR-214, was unlikely to result in efficacy and created additional high-dosing safety concerns; (3) NKTR-214 was less effective than IL-2 alone; (4) the combination of NKTR-214 with nivolumab has yet to demonstrate significant positive results; and (5) as a result, Nektar's public statements as set forth above were materially false and misleading at all relevant times.
Tesaro, Inc. (NASDAQ:TSRO) Class Period: November 4, 2016 to November 14, 2016 Lead Plaintiff Deadline: January 8, 2019
Throughout the class period, Tesaro, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) notwithstanding the completion of the July Public Offering, Tesaro's liquidity position was insufficient to meet its cash flow requirements and fund its existing operations; (ii) accordingly, unbeknownst to investors, an additional public offering of Tesaro common stock was imminent; and (iii) as a result, Tesaro's public statements were materially false and misleading at all relevant times. On July 7, 2016, Tesaro announced the closing of a previously-announced underwritten public offering. Then on November 14, 2016, Tesaro announced another proposed public offering. Following this news, on November 15, 2016, Tesaro stock fell more than 11 percent to close at $131.04 per share.
Aphria Inc. (NYSE:APHA) Class Period: July 17, 2018 to December 4, 2018 Lead Plaintiff Deadline: February 4, 2019
During the class period, Aphria Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Latin American assets acquired by the Company lacked adequate licenses to operate and were overvalued; (2) the acquisition of the Latin American assets would enrich the Company's CEO and other insiders at the expense of shareholders; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: J. Klein, Esq. Empire State Building 350 Fifth Avenue 59th Floor New York, NY 10118 jk@kleinstocklaw.com Telephone: (212) 616-4899 Fax: (347) 558-9665 www.kleinstocklaw.com
